Abstract
Purpose: To evaluate and compare the use of OCP with GnRHa for hypothalamic-pituitary suppression in poor responder IVF patients.
Methods: Retrospective analysis of IVF-ET cycles of poor responders. Hypothalamic-pituitary suppression with OCP (Group I, n = 29) or GnRHa (Group II, n = 52), followed by stimulation with gonadotropin, oocyte retrieval, and embryo transfer. Baseline characteristics and cycle outcomes were compared.
Results: 73 women underwent 81 cycles from 1/1/1999 to 1/1/2000. Baseline characteristics were similar. 31/81 (38%) cycles were cancelled (Group I, 14/29 (48%) vs. Group II, 17/52 (33%), NS). Cycle outcomes including amount of gonadotropin, number of eggs retrieved, number of embryos transferred, and embryo quality were similar. Patients in Group I required fewer days of stimulation to reach oocyte retrieval. Pregnancy outcomes were similar in the two groups.
Conclusion: Our retrospective analysis revealed no improvement in IVF cycle outcomes in poor responders who received OCPs to achieve hypothalamic-pituitary suppression instead of GnRHa.
Keywords: GnRHa, IVF cycle, OCP, poor responder
Full Text
The Full Text of this article is available as a PDF (49.9 KB).
REFERENCES
- 1.Faber BM, Mayer J, Cox B, Jones D, Toner JP, Oehninger S, Muasher SJ. Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril. 1998;69:826–830. doi: 10.1016/s0015-0282(98)00040-5. [DOI] [PubMed] [Google Scholar]
- 2.Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril. 2000;73:667–676. doi: 10.1016/s0015-0282(99)00630-5. [DOI] [PubMed] [Google Scholar]
- 3.Hu Y, Maxson WS, Hoffman DI, Ory SJ, Eager S, Dupre J, Lu C. Maximizing pregnancy rates and limiting higher-order multiple conceptions by detemining the optimal number of embryos to transfer based on quality. Fertil Steril. 1997;69:650–654. doi: 10.1016/s0015-0282(98)00024-7. [DOI] [PubMed] [Google Scholar]
- 4.Shoham Z, Schachter M, Loumaye E, Weissman A, MacNamee M, Insler V. The luteinizing hormone surge-the final stage in ovulation induction: Modern aspects of ovulation triggering. Fertil Steril. 1995;64:237–247. doi: 10.1016/s0015-0282(16)57717-6. [DOI] [PubMed] [Google Scholar]
- 5.Gonen Y, Jacobson W, Casper RF. Gonadotropin suppression with oral contraceptives before in vitro fertilization. Fertil Steril. 1990;53:282–287. doi: 10.1016/s0015-0282(16)53282-8. [DOI] [PubMed] [Google Scholar]
- 6.Burry KA, Greenberg LH, Patton PE. Ovarian response in superovulated cycles after suppression with oral contraceptive steroids. Am J Obstet Gynecol. 1991;164:1592–1596. doi: 10.1016/0002-9378(91)91441-x. [DOI] [PubMed] [Google Scholar]
- 7.Cohen J, Debache C, Solal P, Serkine AM, Achard B, Loffredo V. Results of planned in-vitro fertilization programming through the pre-administration of the oestrogen-progesterone combined pill. Hum Reprod. 1987;2:7–9. doi: 10.1093/oxfordjournals.humrep.a136491. [DOI] [PubMed] [Google Scholar]
- 8.Biljan MM, Mahutte NG, Dean N, Hemmings R, Bissonnette F, Lin Tan S. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil Steril. 1998;70:1063–1069. doi: 10.1016/s0015-0282(98)00333-1. [DOI] [PubMed] [Google Scholar]
- 9.Lindheim SR, Barad DH, Witt BR, Ditkoff E, Sauer MV. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation. J Assist Reprod Genet. 1996;13:745–747. doi: 10.1007/BF02066431. [DOI] [PubMed] [Google Scholar]
- 10.Patton PE, Burry KA, Wolf DP, Kiessling AA, Craemer MJ. The use of oral contraceptives to regulate oocyte retrieval. Fertil Steril. 1988;49:716–718. [PubMed] [Google Scholar]
- 11.Benadiva CA, Ben-Rafael Z, Blasco L, Tureck R, Mastroianni L, Jr., Flickinger GL. Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives. Fertil Steril. 1988;50:516–518. [PubMed] [Google Scholar]
- 12.Karande V, Morris R, Rinehart J, Miller C, Rao R, Gleicher N. Limited success using the “flare” protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization. Fertil Steril. 1997;67:900–903. doi: 10.1016/s0015-0282(97)81403-3. [DOI] [PubMed] [Google Scholar]
- 13.Toth TL, Awward JT, Veeck LL, Jones HW, Muasher SJ. Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotrpin values in an in vitro fertilization program. J Reprod Med. 1996;41:321–326. [PubMed] [Google Scholar]
- 14.Brzyski RG, Muasher RJ, Droesh K, Simonetti S, Jones GS, Rosenwaks Z. Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and folliclestimulating hormone for oocyte recruitment. Fertil Steril. 1988;50:917–921. doi: 10.1016/s0015-0282(16)60372-2. [DOI] [PubMed] [Google Scholar]
- 15.Karande VC, Jones GS, Veeck LL, Muasher SJ. High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients. Fertil Steril. 1990;53:486–489. doi: 10.1016/s0015-0282(16)53345-7. [DOI] [PubMed] [Google Scholar]
- 16.Olivennes F, Righini C, Fanchin R, Torrisi C, Hazout A, Glissant M, et al. Aprotocol using a low dose of gonadotropin-releasing hormone agonist might be the best protocol for patients with high follicle-stimulating hormone concentration on day 3. Hum Reprod. 1996;11:1169–1172. doi: 10.1093/oxfordjournals.humrep.a019348. [DOI] [PubMed] [Google Scholar]
- 17.Salat-Baroux J, Rotten D, Alvarez S, Antoine JM. Comparison of growth hormone responses to growth hormone-releasing factor and clonidine in women with normal or poor ovarian response to gonadotropin stimulation. Fertil Steril. 1993;60:791–799. doi: 10.1016/s0015-0282(16)56278-5. [DOI] [PubMed] [Google Scholar]